Or...Enter your Email


Useful Sites



[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]





U.S. Dry Cleaning Corp. (UDRY.OB): Cleaning up Your Portfolio?

QualityStocks (October 14th, 2008) Writes:

U.S. Dry Cleaning (UDRY) operates 60 dry cleaning stores throughout its home state of California, Hawaii and Virginia. The company also provides commercial dry cleaning services to hotels across the U.S. In order to bolster market share, U.S. Dry Cleaning is highly acquisitive, averaging a couple of acquisitions per quarter thus far in 2008. The company generally looks for stores or chains of dry cleaning shops that have about $5 million in annual revenue. U.S. Dry Cleaning had nearly $13 million in sales for 2007.

The company is also seeking to enter new markets across the U.S. via acquisitions. U.S. Dry Cleaning recently announced that it made purchases to enter new markets in Indiana and Tennessee. The company said earlier this month that paid almost $800,000 to gain nearly $8 million in sales by buying 25 cleaning centers in the Indianapolis area. It was the company’s fourth acquisition in 2008.

...

U.S. Dry Cleaning Corp. (UDRY.OB): Cleaning up Your Portfolio?

QualityStocks (October 14th, 2008) Writes:

U.S. Dry Cleaning (UDRY) operates 60 dry cleaning stores throughout its home state of California, Hawaii and Virginia. The company also provides commercial dry cleaning services to hotels across the U.S. In order to bolster market share, U.S. Dry Cleaning is highly acquisitive, averaging a couple of acquisitions per quarter thus far in 2008. The company generally looks for stores or chains of dry cleaning shops that have about $5 million in annual revenue. U.S. Dry Cleaning had nearly $13 million in sales for 2007.

The company is also seeking to enter new markets across the U.S. via acquisitions. U.S. Dry Cleaning recently announced that it made purchases to enter new markets in Indiana and Tennessee. The company said earlier this month that paid almost $800,000 to gain nearly $8 million in sales by buying 25 cleaning centers in the Indianapolis area. It was the company’s fourth acquisition in 2008.

...

Indiana Stocks

Fred Fuld (October 14th, 2008) Writes:
Indiana is perhaps best known by its world famous Indianapolis 500 motorsports race, but there is indeed much more to this state. It is also a fast growing and very diverse state. The following are interesting facts about Indiana:1. Livestock and poultry occupations employ over 42,000 in Indiana.2. There are three biodiesel plants in Indiana, and one under construction.3. There are 12 ethanol plants operating within the state and together they produce over 1 billion gallons of ethanol.4. A third of Indiana’s soybean production is exported.5. Indiana’s tourism industry contributes almost $7 billion to the economy.6. Indiana’s top manufacturing industries are: transportation equipment, chemicals, and primary metals.7. The manufacturing industry employs approximately 640,000 workers in the state.8. Indiana’s coal industry provides the state with over 2,000 jobs.9. International manufacturing firms with operations in Indiana employ ...

Eli Lilly with Issues to Address - Analyst Blog

Zacks Market Commentaries (October 1st, 2008) Writes:

Indianapolis-based Eli Lilly and Co.Â’s (LLY) leading product is Zyprexa, a treatment for schizophrenia and bipolar disorder. Zypadhera, the trade name in Europe for the long-acting formula of Zyprexa, was recommended for approval by the Committee for Medicinal Products for Human Use in September. We expect to hear back from E.U. regulators within the next few months.

In April and September, Alimta received approval in combination with cisplatin in the E.U. and U.S. for first-line treatment of non-small cell lung cancer. According to the management, the drug currently holds 20% market share in the second-line indication.

We also expect Lilly to follow the approval of Cymbalta with the launch of a DTC campaign for the fibromyalgia indication, which should help to extend the very strong sales growth of the drug.

Although we believe the underlying fundamentals of the company remain solid, the recent pipeline setbacks and lack of clarity surrounding antiplatelet

...

Newsletter

First Name:

Email:


More Options

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.